December 1, 2017  TesoRx Pharma And ASKA Pharmaceutical Expand Territory And Scope Of Partnering Agreement For TesoRx's Oral Testosterone Product - ASKA makes Equity Investment into TesoRx

November 30, 2017  TesoRx Announces Commencement of Enrollment of a Clinical Trial Evaluating Novel Oral Testosterone Replacement Therapy in Patients with Hypogonadism

April 27, 2017  ASKA and TesoRx Announce TSX-011 (Oral Testosterone) Proceeding to Human Studies Following Successful PK Study Results

January 9, 2017  TesoRx Announces Creation of LIPAC Oncology and Advancement of Oncology Pipeline   

January 9, 2017  ASKA and TesoRx Announce Partnership to Develop Oral Testosterone
for the Japanese Market


June 8, 2016  FDA grants orphan designation for TesoRx's unmodified Testosterone treatment for Constitutional Delay in Growth in Puberty (CDGP) for boys

News - February 2016 - Landmark NIH-funded Testosterone Study finds modest benefits for men


April 3, 2015  Official Opening of TesoRx Centre of Excellence at Western University


    October 20, 2014  TesoRx and Aspen Group Conclude Investment and Licensing Agreement

      News - August 5, 2014 Tesorx crosses all of its ‘T’s’ with $10M series B-1

        August 5, 2014  TesoRx Closes $10M in Funding, Secures Key Patent and Hires
        Renowned Urologist as Chief Medical Officer

          News - June 2014 TesoRx Featured in CEO/CFO Magazine

            May 16, 2014 TesoRx Announces Participation at the American Urological Association
            (AUA) 2014 Conference.


              August 28, 2013  TesoRx and CoreRx Announce Joint Venture to Manufacture First-in-Class Oral Testosterone Drug


                December 31, 2010  TesoRx closes Series A funding round.

                  July 30, 2010  TesoRx licenses Testosterone Replacement Therapy technology

                  April 30, 2010  Well-known pharma personality forms TesoRx